Oprah and Serena Williams Team Up to Promote the Joys of Weight Loss Drugs
Oprah Winfrey recently hosted an event for her podcast dedicated to the topic of GLP-1 medications, a.k.a. weight loss drugs such as Ozempic. Winfrey had opened up about using the medication in 2023 and how it changed her life, and… Read more…
Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety
by Ariana M. Chao, Adam Gilden, Thomas A. Wadden Glucagon-like peptide-1 (GLP-1)-based medications, such as semaglutide and tirzepatide, have transformed obesity care. However, rising use brings concerns about side effects, long-term outcomes, and unregulated products. Ensuring safe access requires oversight, monitoring, and coordinated clinical care. In this Perspective, Ariana Chao, Adam Gilden and Thomas Wadden […]
Eli Lilly’s Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain Relief
The rising popularity of weight loss drugs is a key reason healthcare company Eli Lilly (NYSE: LLY) has been soaring in value in recent years. It has a leading GLP-1 drug that’s approved for diabetes (Mounjaro) and weight loss (Zepbound). Those products are generating billions in revenue for the business every quarter. What’s encouraging, however, […]
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference
Novo Nordisk’s CEO spoke about GLP-1 pricing and Pfizer’s CEO spoke about the company’s obesity ambitions while at the JPMorgan Healthcare Conference.
Who’s Most Likely to See Hair Loss on GLP-1s?
We have heard Reddit horror stories about GLP-1 users losing their hair. Now, there’s finally a study corroborating these claims. The researchers concluded that patients with pre-existing hair loss might be at risk of losing more hair while using these drugs. — ULO HAIR GROWTH OFFERINGS (15% OFF, FOREVER): https://ulo.co/discount/perfecthairhealth15 Not sure where to start […]
The Ozempic era might be over already
In the three years since Ozempic entered the national consciousness, the brand name has become so ubiquitous that it is used as a shorthand for all GLP-1 receptor agonists (Wegovy, Mounjaro, et al), in the way that all vacuum cleaners are Hoovers and all sticky tape is Sellotape. The weight-loss treatment was hailed as a […]
Live from JPM 2026, a sit-down with Novo Nordisk’s CEO and VC Bob Nelsen
How did an office clerk become CEO of a major pharmaceutical company? What’s “Project Prometheus”? And what’s next in drug R&D? Allison, Adam, and Elaine are asking those questions live from the J.P. Morgan Healthcare Conference in San Francisco. Read the rest…
Sneaky new trend companies are using to target GLP-1 and other weight-loss drug users
While the nutritional needs of GLP-1 users are not drastically different from the general population, according to a dietician, the key distinction lies in reduced food intake
More Than One in Four Adults Eligible for GLP-1 Receptor Agonists
WEDNESDAY, Jan. 14, 2026 — More than one-quarter of adults aged 25 to 64 years from 99 countries are eligible to receive a glucagon-like peptide-1 (GLP-1) receptor agonist, according to a research letter published in the February issue of The…
Whoopi Goldberg Demands Robert F. Kennedy Jr. Make GLP-1 Weight Loss Drugs More Accessible On ‘The View’: “You’re All About Making The Country Healthier”
Oprah Winfrey stopped by The View to discuss her experience taking weight loss drugs.